Literature DB >> 10698509

Neu differentiation factor/heregulin induction by hepatocyte and keratinocyte growth factors.

P Castagnino1, M V Lorenzi, J Yeh, D Breckenridge, H Sakata, B Munz, S Werner, D P Bottaro.   

Abstract

Hepatocyte growth-factor (HGF) is a potent, widely produced, pleiotropic mediator of mesenchymal-epithelial interaction. In a study of changes in gene expression initiated by HGF in Balb/MK keratinocytes, we observed the induction of Neu-differentiation factor (NDF) mRNA (also known as heregulin, or HRG). Further characterization of the regulation of NDF expression in Balb/MK keratinocytes revealed potent induction by keratinocyte growth factor (KGF) and epidermal growth factor (EGF), but not by HGF/NK2, an alternative HGF isoform with motogenic but not mitogenic or morphogenic activities. Sustained treatment (8 h) of Balb/MK cells with KGF stimulated secretion of mature NDF protein into the culture medium, and Balb/ MK cells treated with purified recombinant NDF protein showed increased DNA synthesis. We also found evidence of NDF induction in two models of tissue repair in mice: in full-thickness skin wounds, following locally increased KGF production, and in kidney after partial hepatectomy, following elevation of circulating HGF levels. These results reveal that mesenchymally-derived HGF and KGF can activate autocrine NDF signaling in their epithelial targets, and suggest that this mechanism contributes to the coordination of stages of wound repair, and possibly development, where these growth factors act in concert to direct epithelial proliferation, morphogenesis and differentiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698509     DOI: 10.1038/sj.onc.1203357

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis.

Authors:  Markus Müller; Alessandro Morotti; Carola Ponzetto
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

2.  Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation.

Authors:  Susanne V Allander; Peter B Illei; Yidong Chen; Cristina R Antonescu; Mike Bittner; Marc Ladanyi; Paul S Meltzer
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling.

Authors:  Fabiola Cecchi; Deborah Pajalunga; C Andrew Fowler; Aykut Uren; Daniel C Rabe; Benedetta Peruzzi; Nicholas J Macdonald; Davida K Blackman; Stephen J Stahl; R Andrew Byrd; Donald P Bottaro
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

4.  Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes.

Authors:  S W Stoll; S Kansra; S Peshick; D W Fry; W R Leopold; J F Wiesen; M Sibilia; T Zhang; Z Werb; R Derynck; E F Wagner; J T Elder
Journal:  Neoplasia       Date:  2001 Jul-Aug       Impact factor: 5.715

5.  Effects of multiple agents on epithelial differentiation of rabbit adipose-derived stem cells in 3D culture.

Authors:  Hongbin Li; Yuemin Xu; Qiang Fu; Chao Li
Journal:  Tissue Eng Part A       Date:  2012-06-13       Impact factor: 3.845

Review 6.  Roles for neuregulins in human cancer.

Authors:  Christophe Stove; Marc Bracke
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

7.  Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma.

Authors:  R M Gemmill; M Zhou; L Costa; C Korch; R M Bukowski; H A Drabkin
Journal:  Br J Cancer       Date:  2005-06-20       Impact factor: 7.640

8.  Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.

Authors:  Keigo Mitsui; Masaoki Yonezawa; Atsushi Tatsuguchi; Seiichi Shinji; Katya Gudis; Shu Tanaka; Shunji Fujimori; Choitsu Sakamoto
Journal:  BMC Cancer       Date:  2014-11-22       Impact factor: 4.430

9.  HRG-β1-driven ErbB3 signaling induces epithelial-mesenchymal transition in breast cancer cells.

Authors:  Jinkyoung Kim; Hoiseon Jeong; Youngseok Lee; Chungyeul Kim; Hankyeom Kim; Aeree Kim
Journal:  BMC Cancer       Date:  2013-08-12       Impact factor: 4.430

Review 10.  Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models.

Authors:  Paul W Finch; Lawrence J Mark Cross; Daniel F McAuley; Catherine L Farrell
Journal:  J Cell Mol Med       Date:  2013-09       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.